Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us

The Bandish Group

Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us
Jackie Bandish
February 7, 2024

2023 top 10 biopharma mergers and acquisitions

Jackie Bandish
February 7, 2024

The biopharma industry mergers and acquisitions in 2023 did not outdo the highs of 2019 but they did surpass 2022, 2021, and 2020 with $115.8 million in total. Topping the 2023 list is Pfizer’s $43 billion merger with Seagen.

Click here to read the entire article.

Newer PostThe #1 mistake to avoid in a job interview
Older PostThe 10 most anticipated drug launches of 2024
Back to Top
Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us
The Bandish Group, LLC, Bucks County, PA267-483-5233info@bandishgroup.com

Headquarters: Greater Philadelphia Area